This HTML5 document contains 33 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
rdfshttp://www.w3.org/2000/01/rdf-schema#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
ncihttp://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
nci:C2401
rdf:type
owl:Class
rdfs:label
Tyrosinase Peptide
rdfs:subClassOf
_:vb721664 _:vb721665 _:vb721666 _:vb721663 nci:C912
nci:P106
Amino Acid, Peptide, or Protein Pharmacologic Substance
nci:P108
Tyrosinase Peptide
nci:P207
C0338254
nci:P303
Melanoma
nci:P325
<n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>A protein that is made from tumor cells and is used in a vaccine against melanoma. A tyrosinase peptide vaccine may stimulate the body&#39;s immune system to find and kill melanoma cells.</n0:def-definition><n0:def-source>NCI-GLOSS</n0:def-source></n0:ComplexDefinition>
nci:P329
42338
nci:P330
42338
nci:P366
Tyrosinase_Peptide
nci:P90
<n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Tyrosinase Peptides</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>tyrosinase peptide</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI-GLOSS</n0:term-source><n0:source-code>CDR0000045460</n0:source-code></n0:ComplexTerm> <n0:ComplexTerm xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:term-name>Tyrosinase Peptide</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>
nci:P97
<n0:ComplexDefinition xmlns:n0="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#"><n0:def-definition>One of a number of recombinant peptides consisting of amino acid residues of the enzyme tyrosinase, a protein frequently expressed by melanoma cells. Vaccination with tyrosinase peptide may stimulate cytotoxic T lymphocyte response against tyrosinase-expressing tumor cells, resulting in decreased tumor growth. (NCI04)</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>
nci:code
C2401
Subject Item
_:vb721663
rdf:type
owl:Restriction
owl:onProperty
nci:R125
owl:someValuesFrom
nci:C19053
Subject Item
_:vb721664
rdf:type
owl:Restriction
owl:onProperty
nci:R124
owl:someValuesFrom
nci:C45548
Subject Item
_:vb721665
rdf:type
owl:Restriction
owl:onProperty
nci:R125
owl:someValuesFrom
nci:C40912
Subject Item
_:vb721666
rdf:type
owl:Restriction
owl:onProperty
nci:R72
owl:someValuesFrom
nci:C12543